Mycoplasma PCR Detection Kit

Cat. No.
G238
Unit
100 rxn
Price
$219.00
Cat. No. G238
Name Mycoplasma PCR Detection Kit
Description

Save when you buy abm's Mycoplasma PCR Detection Kit bundled with MycoAway™ Elimination Cocktail (Cat. No. G398). Click here and add this bundle to your cart to save instantly!

Enjoy superior performance at lower costs!

abm's Mycoplasma PCR Detection Kit offers highly specific and sensitive detection of 200+ strains of Mycoplasma in less than 2 hours. This bestselling kit is designed to minimize false positives, ensuring quick and reliable routine screening of cell cultures. A recent official publication by a national public health agency found that our kit out-performs Sigma and Lonza's kits while being 6X less expensive than ATCC's kit (Russell et al., 2020).

Mycoplasma species are highly undesirable, easily acquired, and notoriously difficult to detect, altering infected cells at the molecular level and leading to visible changes in cell morphology and growth characteristics. Timely detection of Mycoplasma in cell culture media is recommended in order to deter wide-spread contamination and save on the costly efforts of elimination. Our proprietary MasterMix formulation contains a gel loading dye, making it convenient for gel electrophoresis.

Kit Features:

  • No DNA isolation needed: Add cell culture media sample directly to PCR reaction
  • Rapid and Comprehensive: Detect 200+ Mycoplasma species in less than 2 hours
  • Highly Sensitive and Specific: Demonstrated the highest true positive and lowest false positive rates compared to competing kits
  • Easy-to-use: Includes ready-to-use primer mix and positive control
  • 6X less expensive per sample compared to competing kits (Russel et al., 2020)
  • Out-performs Sigma and Lonza's kits (Russel et al., 2020)
  • Combine with our bestselling Mycoplasma Elimination Cocktail (Cat. No. G398) to eliminate 70+ species of Mycoplasma
  • Want to cover more species and confidently detect false negative results with an internal PCR control? Try our new Mycoplasma Pro PCR Detection Kit (Cat. No. G239)
Product Components Quantity
BlasTaq™ 2X PCR MasterMix
1.25 ml
Primer Mix
100 μl
Positive Control
250 μl
Nuclease-Free H2O
1.0 ml

Customer Testimonial

"The mycoplasma detection kit we received from ABM worked very well. It was fast, easy to use, and, with the included controls, the results were very easy to interpret. We will purchase this kit again the next time we are in need of mycoplasma detection."

- Haylie Romero, University of California San Diego

An official publication by a national public health agency finds our kit out-performs Sigma and Lonza's kits:

Russell, B. J., Horiuchi, K., Velez, J. O., Goodman, C. H., & Johnson, B. W. (2020). Mycoplasma detection in a historical arbovirus repository: Commercial kit comparison and implications for improved repository management. Journal of virological methods, 276, 113769. https://doi.org/10.1016/j.jviromet.2019.113769

ISO 13485:2016 MDSAP Certified

ISO 13485:2016 MDSAP Certified
Our PCR Products are manufactured under a Quality Management System conforming with ISO 13485:2016 as certified by Intertek (a MDSAP recognized auditing organization).

Why test your cells for Mycoplasma?

Due to its small size, Mycoplasma can be present in your growth media without being visibly detected. This can cause significant errors in your experiments due to its effects on:

  • proliferation
  • metabolism
  • gene synthesis & processing
  • adhesion properties
  • and more

Many publishers now request Mycoplasma testing to be reported along with manuscript submissions to ensure accuracy in data reporting. Visit our learning resources center to read more about Mycoplasma contamination.

Unit 100 rxn
Storage Condition

Store at -20°C. This product is stable for 2 years from the date of shipping if stored and handled properly. 

Material Citation If use of this material results in a scientific publication, please cite the material in the following manner: Applied Biological Materials Inc, Cat. No. G238
  • Bahreyni, A., Liu, H., Mohamud, Y., Xue, Y. C., Zhang, J., & Luo, H. (2022). A new miRNA-Modified coxsackievirus B3 inhibits triple negative breast cancer growth with improved safety profile in immunocompetent mice. Cancer Letters, 548, 215849. https://doi.org/10.1016/j.canlet.2022.215849

    Conrad, S. J., Silva, R. F., Hearn, C. J., Climans, M., & Dunn, J. R. (2018). Attenuation of Marek's disease virus by codon pair deoptimization of a core gene. Virology, 516, 219-226. https://doi.org/10.1016/j.virol.2018.01.020

    Dogra, S., Elayapillai, S. P., Qu, D., Pitts, K., Filatenkov, A., Houchen, C. W., ... & Hannafon, B. N. (2023). Targeting doublecortin-like kinase 1 reveals a novel strategy to circumvent chemoresistance and metastasis in ovarian cancer. Cancer Letters, 578, 216437. https://doi.org/10.1016/j.canlet.2023.216437

    Du, L., Liu, W., Aldana-Masangkay, G. et al. SUMOylation inhibition enhances dexamethasone sensitivity in multiple myeloma. J Exp Clin Cancer Res 41, 8 (2022). https://doi.org/10.1186/s13046-021-02226-9

    Favaretto, G., Rossi, M.N., Cuollo, L. et al. Neutrophil-activating secretome characterizes palbociclib-induced senescence of breast cancer cells. Cancer Immunol Immunother 73, 113 (2024). https://doi.org/10.1007/s00262-024-03695-5

    Jia, B., Yin, X., Wang, Y., Qian, J., He, Y., Yang, C., … Meng, X. (2020). CircRNA-PTN Sponges miR-326 to Promote Proliferation in Hepatocellular Carcinoma. OncoTargets and Therapy, 13, 4893–4903. https://doi.org/10.2147/OTT.S251300

    Kalejaiye, T. D., Bhattacharya, R., Burt, M. A., Travieso, T., Okafor, A. E., Mou, X., ... & Musah, S. (2022). SARS-CoV-2 employ BSG/CD147 and ACE2 receptors to directly infect human induced pluripotent stem cell-derived kidney podocytes. Frontiers in Cell and Developmental Biology, 10, 855340. https://doi.org/10.3389/fcell.2022.855340

    Kurden-Pekmezci, A., Cakiroglu, E., Eris, S., Mazi, F. A., Coskun-Deniz, O. S., Dalgic, E., ... & Senturk, S. (2023). MALT1 paracaspase is overexpressed in hepatocellular carcinoma and promotes cancer cell survival and growth. Life Sciences, 323, 121690. https://doi.org/10.1016/j.lfs.2023.121690

    Lee, M. H., Ratanachan, D., Wang, Z., Hack, J., Adbulrahman, L., Shamlin, N. P., ... & Schaue, D. (2023). Adaptation of the tumor antigen presentation machinery to ionizing radiation. The Journal of Immunology, 211(4), 693-705. https://doi.org/10.4049/jimmunol.2100793

    Li, F., Kitajima, S., Kohno, S., Yoshida, A., Tange, S., Sasaki, S., ... & Takahashi, C. (2019). Retinoblastoma inactivation induces a protumoral microenvironment via enhanced CCL2 secretion. Cancer Research, 79(15), 3903-3915. https://doi.org/10.1158/0008-5472.CAN-18-3604

    Lorusso, B., Cerasoli, G., Falco, A., Frati, C., Graiani, G., Madeddu, D., ... & Lagrasta, C. (2022). Β-blockers activate autophagy on infantile hemangioma-derived endothelial cells in vitro. Vascular pharmacology, 146, 107110. https://doi.org/10.1016/j.vph.2022.107110

    Miranda, L., Mandrich, L., Massa, S., Nutile, T., Crovella, C., De Rosa, I., ... & Caputo, E. (2025). Breast Cancer Tissues and Organoids BioBank: Constitution, Research Activities and Samples Access. Organoids, 4(1), 5. https://doi.org/10.3390/organoids4010005

    Nasser, A. M., Melamed, L., Wetzel, E. A., Chang, J. C. C., Nagashima, H., Kitagawa, Y., ... & Miller, J. J. (2024). CDKN2A/B homozygous deletion sensitizes IDH-mutant glioma to CDK4/6 inhibition. Clinical Cancer Research, 30(14), 2996-3005. https://doi.org/10.1158/1078-0432.CCR-24-0562

    Pelullo, M., Nardozza, F., Zema, S., Quaranta, R., Nicoletti, C., Besharat, Z. M., ... & Bellavia, D. (2019). Kras/ADAM17-dependent Jag1-ICD reverse signaling sustains colorectal cancer progression and chemoresistance. Cancer research, 79(21), 5575-5586. https://doi.org/10.1158/0008-5472.CAN-19-0145

    Pelullo, M., Zema, S., De Carolis, M., Cialfi, S., Giuli, M. V., Palermo, R., ... & Bellavia, D. (2022). 5FU/Oxaliplatin-induced jagged1 cleavage counteracts apoptosis induction in colorectal cancer: A novel mechanism of intrinsic drug resistance. Frontiers in Oncology, 12, 918763. https://doi.org/10.3389/fonc.2022.918763

    Roye, Y., Bhattacharya, R., Mou, X., Zhou, Y., Burt, M. A., & Musah, S. (2021). A personalized glomerulus chip engineered from stem cell-derived epithelium and vascular endothelium. Micromachines, 12(8), 967. https://doi.org/10.3390/mi12080967

    Zhong, N., Li, D., Wang, B., Kovalchuk, O., & Kovalchuk, I. (2023). Cannabinol inhibits cell growth and triggers cell cycle arrest and apoptosis in cancer cells. Biocatalysis and Agricultural Biotechnology, 48, 102627. https://doi.org/10.1016/j.bcab.2023.102627

    Zhou, Q., Pichlmeier, S., Denz, A. M., Schreiner, N., Straub, T., Benitz, S., ... & Regel, I. (2024). Altered histone acetylation patterns in pancreatic cancer cell lines induce subtype‑specific transcriptomic and phenotypical changes. International journal of oncology, 64(3), 1-12. https://doi.org/10.3892/ijo.2024.5614

    Zhu, Q., Zhang, X., Lu, F. et al. RUNX1-BMP2 promotes vasculogenic mimicry in laryngeal squamous cell carcinoma via activation of the PI3K-AKT signaling pathway. Cell Commun Signal 22, 227 (2024). https://doi.org/10.1186/s12964-024-01605-x

verified customer

Submitted on: 2023-12-13 21:21:25

The reviewer received points from abmVacations+ Loyalty Program in thanks for sharing their results on the use of this product with the scientific community.